0001729149false00017291492024-06-062024-06-06


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 6, 2024
 

Viemed Healthcare, Inc.
(Exact name of registrant as specified in its charter)
  
British Columbia, Canada
001-38973N/A
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(I.R.S. Employer
Identification No.)
625 E. Kaliste Saloom Rd.
Lafayette, Louisiana
70508
(Address of principal executive offices)(Zip Code)
(337) 504-3802
(Registrant’s telephone number, including area code) 

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares, no par value
VMD
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Viemed Healthcare, Inc. (the “Company”) held its Annual & Special Meeting of Shareholders (the “Meeting”) on June 6, 2024. At the Meeting, the Company’s shareholders, upon the recommendation of the Company’s Board of Directors (the “Board”), approved the Company’s 2024 Long Term Incentive Plan (the “Plan”). A summary of the Plan is set forth in the Company’s Management Information and Proxy Circular filed with the Securities and Exchange Commission on April 26, 2024. That summary and the above description of the Plan do not purport to be complete and are qualified in their entirety by reference to the Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.


Item 5.07. Submission of Matters to a Vote of Security Holders.

At the Meeting, the Company's shareholders voted on: (1) eight nominated directors to be elected to the Board to serve until the close of the next annual meeting of shareholders or until their successors are elected; (2) the appointment of Ernst & Young LLP as auditors of the Company for the fiscal year ending December 31, 2024 and authorizing the Board to fix their remuneration and (3) an ordinary resolution to ratify, confirm, and approve the Plan.

The tables below set forth the number of votes cast for, against, or withheld, and the number of broker non-votes for each matter voted on by the Company’s shareholders.

1. Election of Directors

Each of the eight nominees listed below were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected.

NameVotes For% ForVotes Withheld% Withheld
Casey Hoyt24,576,92897.47%638,9852.53%
W. Todd Zehnder24,488,10597.11%727,8082.89%
William Frazier24,167,03195.84%1,048,8824.16%
Randy Dobbs24,853,88298.56%362,0311.44%
Nitin Kaushal21,286,56484.42%3,929,34915.58%
Timothy Smokoff21,750,40286.26%3,465,51113.74%
Bruce Greenstein20,524,21281.39%4,691,70118.61%
Sabrina Heltz23,970,29395.06%1,245,6204.94%

The number of broker non-votes for all directors was 4,302,487.

2. Appointment of Auditors

The shareholders approved the appointment of Ernst & Young LLP as auditors of the Company for the fiscal year ending December 31, 2024 and the authorization of the Board to fix their remuneration.

Votes For% ForVotes Withheld% WithheldBroker Non-Votes
29,420,86999.67%97,5310.33%—

3. Security Based Compensation Plan
The shareholders passed an ordinary resolution to ratify, confirm, and approve the Plan.


Votes For% For
Votes Against
% Against
Broker Non-Votes
17,451,58569.21%7,764,32830.79%4,302,487





Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits

Exhibit
Number
Description
104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 6, 2024
 
VIEMED HEALTHCARE, INC.
By:
/s/ Trae Fitzgerald
Trae Fitzgerald
Chief Financial Officer

































vhi2024ltip_01.jpg


vhi2024ltip_02.jpg


vhi2024ltip_03.jpg


vhi2024ltip_04.jpg


vhi2024ltip_05.jpg


vhi2024ltip_06.jpg


vhi2024ltip_07.jpg


vhi2024ltip_08.jpg


vhi2024ltip_09.jpg


vhi2024ltip_10.jpg


vhi2024ltip_11.jpg


vhi2024ltip_12.jpg


vhi2024ltip_13.jpg


vhi2024ltip_14.jpg


vhi2024ltip_15.jpg


vhi2024ltip_16.jpg


vhi2024ltip_17.jpg


vhi2024ltip_18.jpg


vhi2024ltip_19.jpg


vhi2024ltip_20.jpg


vhi2024ltip_21.jpg


vhi2024ltip_22.jpg


vhi2024ltip_23.jpg


vhi2024ltip_24.jpg


vhi2024ltip_25.jpg


vhi2024ltip_26.jpg


vhi2024ltip_27.jpg


vhi2024ltip_28.jpg


vhi2024ltip_29.jpg


vhi2024ltip_30.jpg


vhi2024ltip_31.jpg


vhi2024ltip_32.jpg


vhi2024ltip_33.jpg


vhi2024ltip_34.jpg


vhi2024ltip_35.jpg


vhi2024ltip_36.jpg

v3.24.1.1.u2
Cover
Jun. 06, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 06, 2024
Entity Registrant Name Viemed Healthcare, Inc.
Entity File Number 001-38973
Entity Incorporation, State or Country Code Z4
Entity Address, Address Line One 625 E. Kaliste Saloom Rd.
Entity Address, Postal Zip Code 70508
Entity Address, City or Town Lafayette
Entity Address, State or Province LA
City Area Code 337
Local Phone Number 504-3802
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common shares, no par value
Trading Symbol VMD
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001729149
Amendment Flag false
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more VieMed Healthcare Charts.
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more VieMed Healthcare Charts.